OBGYN

Children’s Home Society of NC Recognizes Child Abuse Prevention Month

Retrieved on: 
Wednesday, March 27, 2024
Research, CHS, OBGYN, Growth, Child, Caregiver, Parent, Risk, Education, News, Hope, Molina Healthcare, Behavior, Ecosystem, Safety, Toy

Greensboro, NC, March 27, 2024 (GLOBE NEWSWIRE) -- Each April Children’s Home Society of NC (CHS) recognizes National Child Abuse Prevention Month to reinforce the importance of families and communities working together to prevent child abuse and neglect.

Key Points: 
  • Greensboro, NC, March 27, 2024 (GLOBE NEWSWIRE) -- Each April Children’s Home Society of NC (CHS) recognizes National Child Abuse Prevention Month to reinforce the importance of families and communities working together to prevent child abuse and neglect.
  • Protective factors are conditions or attributes of individuals, families, communities, or the larger society that mitigate risk and promote healthy development and wellbeing.
  • Child First provides in-home supports to families of young children to help promote healthy attachment and strong parenting skills.
  • Children's Home Society is dedicated to providing top-quality, evidence-based programs and services to children and families throughout North Carolina.

LevLane Advertising Named as Finalist in PRSA Anvil Awards

Retrieved on: 
Tuesday, March 12, 2024
PR, Health, Vulva, Vagina, Feature article, OBGYN, Tactic, Meta, Woman, Kegel exercise, Advertising, Marketing, PRSA

PHILADELPHIA, March 12, 2024 (GLOBE NEWSWIRE) -- LevLane Advertising , one of Philadelphia's oldest independent full-service advertising agencies, has been named a finalist for the prestigious Public Relations Society of America's (PRSA) 2024 Anvil Awards.

Key Points: 
  • PHILADELPHIA, March 12, 2024 (GLOBE NEWSWIRE) -- LevLane Advertising , one of Philadelphia's oldest independent full-service advertising agencies, has been named a finalist for the prestigious Public Relations Society of America's (PRSA) 2024 Anvil Awards.
  • The Anvil Awards recognize the best public relations tactics and campaigns of the year and represent the highest standards of performance in the industry.
  • LevLane's entry for the "Feature Article" category showcased the team's collaboration with Dr. Karla Loken, DO, OBGYN, FACOOG, addressing the gender biases present in women's health advertising.
  • The project team included: Liz Weir, chief marketing officer (LevLane); Kevin Dunn, chief client officer (LevLane); Lauren Stralo, PR supervisor (LevLane); Lauren Hepburn, PR specialist (LevLane); Kelly Ryan, account team (LevLane); Katie Gavin, project management (LevLane); Michele Burns, project team (LevLane); and Dr. Karla Loken, DO, OBGYN, FACOOG, medical affairs.

eClinicalWorks EHR Receives HRSA Approval for UDS+ Submissions for Health Centers Nationwide

Retrieved on: 
Monday, March 25, 2024
Data Management, Health, Technology, Practice Management, Other Health, Software, Community, Fast Healthcare Interoperability Resources, FQHC, Cohort, OBGYN, ONC, Federally Qualified Health Center, EHR, HRSA, Multimedia, Nursing

eClinicalWorks is now a Health Resources and Services Administration (HRSA)--approved EHR vendor for UDS+ submissions and is actively working with Federally Qualified Health Centers (FQHC) to begin voluntary testing for the various HRSA-determined Cohorts.

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240325586555/en/
    The Uniform Data System Modernization (UDS) initiative aims to help health centers streamline annual reporting, improve data quality, and comply with interoperability standards and regulations.
  • UDS+ helps community health centers better track, analyze, and report quality care reporting, which can help improve practice efficiency and aid in data-driven decisions.
  • eClinicalWorks is now a Health Resources and Services Administration (HRSA)--approved EHR vendor for UDS+ submissions and is actively working with Federally Qualified Health Centers (FQHC) to begin voluntary testing for the various HRSA-determined Cohorts.
  • As the vendor of choice for over 800, or roughly 60% of the nation’s health centers, eClinicalWorks offers comprehensive, unified solutions to meet their unique needs, including medical, dental, behavioral health, OBGYN, and vision care.

As Opill Enhances Women's Reproductive Choices Dr. Mary Jane Minkin Highlights Key Differences Between the Progesterone-Only Opill and Traditional Estrogen-Based Contraceptives “The Pill”

Retrieved on: 
Monday, March 11, 2024
Health, FDA, Consumer, Women, Baby, Maternity, General Health, Pharmaceutical, Mother, Birth, Education, OBGYN, Combined oral contraceptive pill, Condom, Risk, Diabetes, Ovulation, Stroke, History, Sale, News, Fertility, Splenic infarction, Smoke, Perrigo, Woman, OTC, Pill, Cancer, Breast cancer, Safety, Progesterone, MUST, Migraine, Birth control

Progesterone-only pills or “mini pills’ are usually used for nursing mothers and those unable to take estrogen-based contraceptives for health reasons and individual medical history.

Key Points: 
  • Progesterone-only pills or “mini pills’ are usually used for nursing mothers and those unable to take estrogen-based contraceptives for health reasons and individual medical history.
  • "Education is key at this juncture to prevent an increase in unintended pregnancies in the coming months.
  • The Opill, significantly differs from the traditional birth control pill in that it is less effective at preventing ovulation when pills are missed or skipped for any reason.
  • The availability of the Opill OTC, or progesterone-only pill, is wonderful news for those women unable to take estrogen or 'The Pill.'

Georgia School of Orthodontics Awards Atlanta Area Youths Complimentary Orthodontic Care

Retrieved on: 
Tuesday, March 5, 2024
Private practice, School, OBGYN, Orthodontics, Georgia School of Orthodontics, Purple Heart, Video, Gift, GSO, Veteran, Student, Dentistry

Atlanta, Georgia--(Newsfile Corp. - March 5, 2024) - In keeping with Georgia School of Orthodontics' (GSO) overarching commitment and mission to give back to the Atlanta community, GSO has selected two Atlanta area children for complimentary orthodontic care through its annual Gift of a Smile program.

Key Points: 
  • Atlanta, Georgia--(Newsfile Corp. - March 5, 2024) - In keeping with Georgia School of Orthodontics' (GSO) overarching commitment and mission to give back to the Atlanta community, GSO has selected two Atlanta area children for complimentary orthodontic care through its annual Gift of a Smile program.
  • Georgia School of Orthodontics GSO) awarded two Atlanta students with free braces and complimentary orthodontic care through its Gift of a Smile program.
  • The three programs combined have provided more than $250,000 in complimentary orthodontic care to over 70 deserving children, adults and veterans in metro Atlanta.
  • "A critical part of Georgia School of Orthodontics' mission is to provide the highest quality orthodontic care at a lower cost than private practice orthodontics in the school's two patient clinics in Atlanta and Duluth.

Ovation Fertility Welcomes Pradeep Warikoo, PhD, HCLD, ELD, CC (ABB), as Cincinnati Lab Director

Retrieved on: 
Tuesday, February 20, 2024
Gynaecology, OBGYN, Doctor of Philosophy, Suite, Research, Physician, Wright, IVF, ELD, ABB, Cryopreservation, Andrology, Obstetrics, University, Jan Vansina, Patient, FIRST, Knowledge, Diagnosis, Laboratory, Partnership, Medical device

Nashville, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Pradeep Warikoo, PhD, HCLD, ELD, CC (ABB), has joined the Ovation® Fertility team as laboratory director of Ovation Fertility Cincinnati, effective February 1, 2024.

Key Points: 
  • Nashville, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Pradeep Warikoo, PhD, HCLD, ELD, CC (ABB), has joined the Ovation® Fertility team as laboratory director of Ovation Fertility Cincinnati, effective February 1, 2024.
  • Dr. Warikoo comes to Ovation from the Bethesda Fertility Center Reproductive Study Lab in Cincinnati, where he has served as scientific director for more than 25 years.
  • “Ovation’s expansion in the Cincinnati area involves a close partnership with our partner physicians at the Institute for Reproductive Health, which combined with Bethesda Fertility Center effective February 1,” says Conor Beardsley, President of Ovation Fertility.
  • He is board certified by the American Board of Bioanalysis as a High Complexity Laboratory Director, Embryology Laboratory Director and Clinical Consultant.

Power to Decide Statement on Over-the-Counter Birth Control Release and Pricing

Retrieved on: 
Monday, March 4, 2024
Bedsider, OBGYN, FDA, OTC, Pharmacy, Safety, Patient, MPH, Birth, Prescription, Insurance, Birth control

WASHINGTON, March 4, 2024 /PRNewswire-PRWeb/ -- Today, the pharmaceutical company Perrigo announced that it will begin shipping the first ever FDA-approved over-the-counter (OTC) daily oral contraceptive pill, Opill, to retailers across the country. This marks a historic advancement in access to contraception, which for decades advocates have been fighting for.

Key Points: 
  • While the OTC birth control pill will greatly increase contraceptive access, the price will continue to be a barrier for many.
  • At Power to Decide, we will continue to push for everyone to have equitable access to take control of their reproductive and sexual health care."
  • Bedsider , a program of Power to Decide, is an evidence-based digital platform that offers medically-accurate, relevant, and resonate information on all aspects of reproductive well-being, including sex, sexual health, and birth control.
  • Find a birth control method that works for you at Bedsider.org.

Myriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor of Women’s Health

Retrieved on: 
Thursday, February 15, 2024
Cancer, OBGYN, Medicine, Education, MYGN, FACMG, Dillard University, Boston Market, Risk, Health, Myriad Genetics, FACOG, Genetics, Risk assessment, Associate, Genetic testing, Biology, Tufts Medical Center, Nursing

SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the appointment of Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor to its women’s health business unit, effective immediately.

Key Points: 
  • SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the appointment of Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor to its women’s health business unit, effective immediately.
  • Dr. Reed brings nearly 15 years of clinical and academic experience rooted in genetics and obstetrics/gynecology to Myriad.
  • “We’re thrilled to welcome Dallas to the Myriad team.
  • She is a passionate women’s health leader and patient advocate who is committed to advancing diversity, equity and inclusion in clinical care and education,” said Melissa Gonzales, president of women’s health, Myriad Genetics.

Montefiore Awarded $2 Million New York State Department of Health Grant to Advance the Education and Training of Community Health Workers

Retrieved on: 
Tuesday, January 9, 2024
SDOH, Pediatrics, Patient, Montefiore Medical Center, Research, Leg, Housing, Food security, Community, Hostos Community College, Work, Psychiatry, Food, CHW, Family, Social determinants of health, Social medicine, CHWI, Transport, Doctor of Philosophy, Workforce, OBGYN, Private law, Education, Social, Nursing

BRONX, N.Y., Jan. 9, 2024 /PRNewswire/ -- There is growing recognition that community health workers (CHWs), local experts who fill gaps between medical care and social services, represent an enormous opportunity to address challenges in healthcare access and improve overall health outcomes. Despite their importance, inconsistencies in education and training prevent CHWs from reaching their full potential. The Community Health Worker Institute (CHWI) at Montefiore has received a $2 million grant from the New York State Department of Health to create a robust program that can serve as a new model for prospective and current CHW instruction and support.

Key Points: 
  • Despite their importance, inconsistencies in education and training prevent CHWs from reaching their full potential.
  • The Community Health Worker Institute (CHWI) at Montefiore has received a $2 million grant from the New York State Department of Health to create a robust program that can serve as a new model for prospective and current CHW instruction and support.
  • The CHWI at Montefiore launched in 2021, and to date, CHWs completed certificate training through Hostos Community College.
  • Most basic CHW training programs include approximately 81 hours of educational activities and 80 hours of on-the-job training.

Teal Health Partners with Leading Health Organizations in a Nationwide Clinical Trial for their Self-Collect Device for Cervical Cancer Screening, the Teal Wand™

Retrieved on: 
Tuesday, January 9, 2024
Cervical cancer, Woman, Privacy, Research, Associate, Collection, Mount Sinai Morningside, SAN, University of Colorado, University of Wisconsin–Madison, University, Johns Hopkins, Yale University, Teal, Disease, Hospital, Health literacy, FDA, Doctor of Philosophy, Head, OBGYN, HPV, Clinical trial, Education, Trial of the century, American Cancer Society, Birth control

SAN FRANCISCO, Jan. 9, 2024 /PRNewswire/ -- Today, in honor of Cervical Cancer Awareness Month, Teal Health, a women's health company focused on increasing access to cervical cancer screenings in the US, announces the SELF-CERV clinical study, in progress at leading health organizations including Johns Hopkins, Yale University, University of Colorado, University of Wisconsin, Washington University, and many more. Teal Health's clinical trial is designed to support FDA submission and approval of their novel at-home self-collect device, the Teal Wand™. By offering an alternative to an in-person doctor's visit for a speculum exam, Teal Health will be able to provide women and people with a cervix a choice and greater access to this critical health screening, on which 1 in 4 women in the US are not up-to-date.

Key Points: 
  • Teal Health's clinical trial is designed to support FDA submission and approval of their novel at-home self-collect device, the Teal Wand™.
  • More than 50% of these diagnoses are later stage and among people who did not have a recent screening.
  • HPV testing is recommended as the preferred cervical cancer screening method by multiple medical guidelines, including the American Cancer Society.
  • This Cervical Cancer Awareness Month, Teal Health is raising awareness about the importance of life-saving cervical cancer screening with their 'Close the Screening Gap' initiative.